Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Protagonist Therapeutics (PTGX) Return on Assets (2018 - 2025)

Historic Return on Assets for Protagonist Therapeutics (PTGX) over the last 9 years, with Q3 2025 value amounting to 0.06%.

  • Protagonist Therapeutics' Return on Assets fell 2200.0% to 0.06% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.06%, marking a year-over-year decrease of 2200.0%. This contributed to the annual value of 0.5% for FY2024, which is 7600.0% up from last year.
  • According to the latest figures from Q3 2025, Protagonist Therapeutics' Return on Assets is 0.06%, which was down 2200.0% from 0.07% recorded in Q2 2025.
  • In the past 5 years, Protagonist Therapeutics' Return on Assets ranged from a high of 0.41% in Q4 2024 and a low of 0.57% during Q1 2023
  • In the last 5 years, Protagonist Therapeutics' Return on Assets had a median value of 0.25% in 2021 and averaged 0.16%.
  • Its Return on Assets has fluctuated over the past 5 years, first soared by 9000bps in 2024, then crashed by -2500bps in 2025.
  • Quarter analysis of 5 years shows Protagonist Therapeutics' Return on Assets stood at 0.35% in 2021, then plummeted by -38bps to 0.48% in 2022, then soared by 52bps to 0.23% in 2023, then skyrocketed by 278bps to 0.41% in 2024, then plummeted by -84bps to 0.06% in 2025.
  • Its last three reported values are 0.06% in Q3 2025, 0.07% for Q2 2025, and 0.08% during Q1 2025.